Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
72,288,934
-
Share change
-
+799,902
-
Total reported value
-
$24,889,114,663
-
Put/Call ratio
-
139%
-
Price per share
-
$344.36
-
Number of holders
-
610
-
Value change
-
+$217,451,545
-
Number of buys
-
299
-
Number of sells
-
299
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q1 2018
As of 31 Mar 2018,
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) was held by
610 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,288,934 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, FMR LLC, Capital World Investors, WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, LOOMIS SAYLES & CO L P, SANDS CAPITAL MANAGEMENT, LLC, HARRIS ASSOCIATES L P, and JANUS HENDERSON GROUP PLC.
This page lists
612
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.